HYDROCODONE POLISTIREX AND CHLORPHENIRAMINE POLISTIREX bulk active fine chemical suppliers

Subscribe to access the full database, or Start Trial
Vendor	Vendor Homepage	Vendor Sku	API Url
RR Scientific	⤷ Start Trial	R6417744	⤷ Start Trial
>Vendor	>Vendor Homepage	>Vendor Sku	>API Url

Last updated: November 13, 2025

Introduction

Hydrocodone Polistirex and Chlorpheniramine Polistirex are extended-release formulations used primarily for managing cough and cold symptoms. These complex pharmaceutical products rely on sourcing high-quality Active Pharmaceutical Ingredients (APIs) to ensure safety, efficacy, and regulatory compliance. Identifying reliable suppliers of these APIs is crucial for pharmaceutical manufacturers aiming to produce consistent, high-quality formulations.

This article examines the primary sources, manufacturing considerations, regulatory landscape, and key players in the bulk supply chain for Hydrocodone Polistirex and Chlorpheniramine Polistirex APIs.

Hydrocodone Polistirex API Sources

Overview of Hydrocodone API

Hydrocodone acrylic complex is an opioid analgesic and antitussive. Its controlled status due to abuse potential mandates strict regulatory oversight during manufacturing, distribution, and sourcing. The API used in Polistirex formulations is a highly purified hydrocodone base, often synthesized through multi-step processes involving controlled precursors.

Major API Producers

Major Domestic Suppliers (United States):

Several US-based manufacturers possess DEA licenses to produce and distribute hydrocodone API. Prominent among these are:
- LGM Pharma: Known for sourcing and distributing controlled APIs, including hydrocodone for research and legitimate pharmaceutical manufacturing, operating under regulatory standards compliant with DEA and FDA.
- Fresenius Kabi: As a global API and finished drug manufacturer, they have facilities capable of producing controlled substances, including hydrocodone, adhering to strict compliance standards.
International Suppliers:
- Mallinckrodt Pharmaceuticals (Ireland/US): Historically a key player in opioid APIs, with extensive facilities for controlled substance manufacturing.
- Noramco Inc.: Specializes in APIs for pharmaceutical and research purposes, including hydrocodone derivatives, with rigorous quality controls aligned with global standards.
- Vitrilab: A supplier focusing on generic APIs, including hydrocodone, primarily serving markets with lenient regulatory environments or as intermediaries.

Manufacturing Considerations

Synthetic Route & Purity: Hydrocodone APIs are synthesized via multi-step chemical processes requiring high purity (>99%) standards. Manufacturers often utilize chemical synthesis from thebaine or codeine sources, employing controlled catalytic reactions.
Regulatory Compliance: Production is subject to DEA regulations in the US and comparable agencies globally. Manufacturers must have appropriate licenses and maintain stringent documentation.
Quality & Stability: APIs must meet USP, EP, or other pharmacopeial standards for potency, purity, and impurity profiles.

Chlorpheniramine Polistirex API Sources

Overview of Chlorpheniramine API

Chlorpheniramine is a first-generation antihistamine used in extended-release formulations such as Polistirex. It is synthesized through well-established organic synthesis routes, often starting from 4-chlorobenzaldehyde, methylamine, and other intermediates.

Leading API Suppliers

Large Pharmaceutical API Manufacturers:
- Heinrich Klenk GmbH & Co. KG: A German supplier known for producing high-quality alkylamine derivatives, including chlorpheniramine.
- Sigma-Aldrich (Merck): Offers bulk chlorpheniramine API conforming to pharmacopeial standards, serving research and production needs.
- Tide Pharmaceuticals: An Indian manufacturer with a sizable portfolio of antihistamine APIs, including chlorpheniramine, compliant with international quality standards.
Regional & Contract Manufacturers:
- Hubei Tiyue Pharmaceutical: A Chinese API manufacturer specializing in antihistamines, with export capabilities to North America and Europe.
- Cipla Limited: An Indian pharmaceutical company providing bulk APIs, including chlorpheniramine, for export and local formulations.

Manufacturing and Quality Highlights

Synthetic Process: Typically involves reduction and alkylation steps from substituted benzaldehyde derivatives, followed by purification protocols ensuring high potency and low impurity levels.
Regulatory Standards: API suppliers must often conform to cGMP protocols, and products need to meet USP, BP, or other pharmacopeial standards to ensure compatibility with Polistirex formulations.
Supply Chain Considerations: Global supply chains for chlorpheniramine APIs involve sourcing intermediates from China or India with subsequent synthesis in certified manufacturing facilities.

Regulatory Landscape and Due Diligence

The manufacturing and procurement of APIs for controlled substances like hydrocodone involve navigating complex regulatory frameworks. The DEA regulates opioid APIs in the US, requiring registrants to obtain controlled substance manufacturing and distribution licenses. Similarly, international suppliers must comply with local drug enforcement agencies and international agreements (such as the International Narcotics Control Board, INCB).

Due diligence includes:

Confirming supplier licensing and compliance with cGMP.
Ensuring third-party audits and quality certifications.
Verifying API batch testing and stability data.
Establishing traceability and documentation for regulatory audits.

Emerging Sources and Trends

Due to tight regulation and legal restrictions, many pharmaceutical companies explore alternative strategies, such as:

Vertical Integration: Manufacturing APIs in-house to control quality and supply chain integrity.
Global Diversification: Sourcing from multiple certified suppliers to mitigate risks associated with regulatory changes or supply disruptions.
Research on Synthetic Routes: Development of more efficient, environmentally friendly synthesis pathways to increase yield and reduce impurities.

Key Players Summary

Category	Major Companies	Focus Area	Region	Notes
Hydrocodone API	Mallinckrodt, Noramco, Fresenius Kabi, LGM Pharma	Controlled substance API	US, Ireland, Global	DEA-licensed, regulated manufacturing
Chlorpheniramine API	Sigma-Aldrich, Heinrich Klenk, Tide Pharmaceuticals, Cipla	Antihistamine API	Global (Europe, India, China)	cGMP compliance essential

Conclusion

Securing reliable bulk sources for Hydrocodone Polistirex and Chlorpheniramine Polistirex APIs demands meticulous vetting of suppliers for regulatory compliance, quality assurance, and supply chain stability. Domestic and international manufacturers, operating under stringent regulatory oversight, provide the necessary APIs for pharmaceutical companies aiming to produce safe and efficacious Polistirex formulations. As the landscape evolves with regulatory changes and supply constraints, diversification and rigorous supplier qualification remain pivotal.

Key Takeaways

Rigorous Compliance: Sourcing APIs for controlled substances like hydrocodone requires adherence to DEA and FDA regulations, with proper licensing being non-negotiable.
Quality Assurance: High purity standards (>99%) and batch consistency are imperative to maintain the safety and efficacy of Polistirex formulations.
Global Suppliers: Major international suppliers from China, India, and Europe are key sources, but due diligence is essential to ensure cGMP compliance.
Supply Chain Risk Mitigation: Diversify sources and establish long-term supply agreements with reputable manufacturers to mitigate potential disruptions.
Regulatory Vigilance: Continuous monitoring of evolving legal frameworks and international controls is necessary to sustain compliant supply chains.

FAQs

1. Are there non-controlled API sources for Hydrocodone Polistirex?
No. Hydrocodone is a controlled substance globally; thus, its API can only be sourced from licensed regulated manufacturers complying with legal controls in the respective jurisdictions.

2. Can I import Hydrocodone and Chlorpheniramine APIs from overseas suppliers?
Importation is subject to strict regulatory approval and licensing, especially for controlled substances like hydrocodone. It requires DEA registration or equivalent authority and compliance with customs and import regulations.

3. How do I verify the quality of API suppliers?
Request certifications including cGMP compliance, Certificate of Analysis (CoA), manufacturing licenses, and audit reports. Conduct third-party audits and review regulatory track records.

4. Are there alternative APIs for cough suppression or antihistamine therapy?
Yes. For cough suppression, alternatives include dextromethorphan. For antihistamines, second-generation agents such as loratadine or cetirizine are available, but they are not equivalent to chlorpheniramine in extended-release formulations.

5. What risks are associated with sourcing APIs from unregulated or questionable suppliers?
Risks include substandard quality, impurities, supply disruptions, legal repercussions, and potential product recalls, which can compromise patient safety and regulatory compliance.

Sources:

U.S. Drug Enforcement Administration (DEA). Controlled Substance Act Regulations; 21 CFR parts 1300–1320.
USP Monographs for Hydrocodone and Chlorpheniramine.
Global Pharmaceutical API supplier catalogs and regulatory filings.
Industry reports on API manufacturing and supply chain management.[1][2][3][4]

Bulk Pharmaceutical API Sources for HYDROCODONE POLISTIREX AND CHLORPHENIRAMINE POLISTIREX